Product Information

BUTRANS 20 MCG/HR PATCH is a brand product labeled by Purdue Pharma LP, priced at $131.0635 per EA under NDC 59011075204. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Jun 30, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BUTRANS 20 MCG/HR PATCH

buprenorphine
$131.0635per EA
DEA Schedule CIII

Strength

20 ug/h

Manufacturer

Purdue Pharma LP

NDC

59011075204

Classification

Brand

Dosage Form

PATCH, EXTENDED RELEASE

Route

TRANSDERMAL

Effective Date

8/19/2026

Active Ingredients

BUPRENORPHINE

Approval Type

New Drug (NDA)

FDA Application

NDA021306

FDA Approved

6/30/2010

TE Code

AB

On Market Since

2/14/2011

Pharmacological Classes

Partial Opioid Agonist
Partial Opioid Agonists

Price Statistics

The NADAC for BUTRANS 20 MCG/HR PATCH has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 37.2%. The table below summarizes its recorded NADAC range and movement.

Current price$131.0635 per EA
All-time high$228.1759 (Dec 27, 2023)
All-time low$95.5562 (Nov 28, 2013)
52-week high$131.2130
52-week low$130.9956
Median price$156.1410
Average price$163.4878
Largest weekly change-42.2% (Jan 3, 2024)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

+0.1%

1M

+0.1%

3M

+0.0%

6M

-0.0%

1Y

-0.1%

3Y

-42.2%

5Y

-36.6%

All

+37.2%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 56% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 56%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of BUTRANS 20 MCG/HR PATCH?

The current National Average Drug Acquisition Cost (NADAC) for BUTRANS 20 MCG/HR PATCH, manufactured by Purdue Pharma LP, is $131.0635 per EA (NDC 59011075204), effective Aug 19, 2026.

How has the price of BUTRANS 20 MCG/HR PATCH changed over time?

Over the history we have for it, the NADAC for BUTRANS 20 MCG/HR PATCH has risen 37.2%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for BUTRANS 20 MCG/HR PATCH?

Since Nov 28, 2013, the NADAC for BUTRANS 20 MCG/HR PATCH has ranged from a low of $95.5562 (Nov 28, 2013) to a high of $228.1759 (Dec 27, 2023), with a median of $156.1410 per EA.

Are there cheaper alternatives to BUTRANS 20 MCG/HR PATCH?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUPRENORPHINE 20 MCG/HR PATCH, is $57.3174 per EA — about 56% below BUTRANS 20 MCG/HR PATCH.

Who manufactures BUTRANS 20 MCG/HR PATCH?

BUTRANS 20 MCG/HR PATCH (NDC 59011075204) is labeled by Purdue Pharma LP, and CMS classifies it as a brand product.